175 related articles for article (PubMed ID: 37602719)
1. Effect of Helicobacter pylori eradication on gastric precancerous lesions: A systematic review and meta-analysis.
Zhu F; Zhang X; Li P; Zhu Y
Helicobacter; 2023 Dec; 28(6):e13013. PubMed ID: 37602719
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis.
Chen HN; Wang Z; Li X; Zhou ZG
Gastric Cancer; 2016 Jan; 19(1):166-75. PubMed ID: 25609452
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS;
JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Helicobacter pylori eradication in preventing metachronous gastric cancer and preneoplastic lesions. A systematic review and meta-analysis.
Khan MY; Aslam A; Mihali AB; Shabbir Rawala M; Dirweesh A; Khan S; Adler DG; Siddiqui A
Eur J Gastroenterol Hepatol; 2020 Jun; 32(6):686-694. PubMed ID: 32355093
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of
Mera RM; Bravo LE; Camargo MC; Bravo JC; Delgado AG; Romero-Gallo J; Yepez MC; Realpe JL; Schneider BG; Morgan DR; Peek RM; Correa P; Wilson KT; Piazuelo MB
Gut; 2018 Jul; 67(7):1239-1246. PubMed ID: 28647684
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
Liu KS; Wong IO; Leung WK
World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
[TBL] [Abstract][Full Text] [Related]
7. Genetic factors in the development of gastric precancerous lesions--a role of Helicobacter pylori ?
Jablonská M; Chlumská A
J Physiol Paris; 2001; 95(1-6):477-81. PubMed ID: 11595478
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development.
Watari J; Chen N; Amenta PS; Fukui H; Oshima T; Tomita T; Miwa H; Lim KJ; Das KM
World J Gastroenterol; 2014 May; 20(18):5461-73. PubMed ID: 24833876
[TBL] [Abstract][Full Text] [Related]
9. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT
Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori eradication may influence timing of endoscopic surveillance for gastric cancer in patients with gastric precancerous lesions: A retrospective study.
Dore MP; Cipolli A; Ruggiu MW; Manca A; Bassotti G; Pes GM
Medicine (Baltimore); 2018 Jan; 97(4):e9734. PubMed ID: 29369216
[TBL] [Abstract][Full Text] [Related]
11.
Panarese A; Galatola G; Armentano R; Pimentel-Nunes P; Ierardi E; Caruso ML; Pesce F; Lenti MV; Palmitessa V; Coletta S; Shahini E
World J Gastroenterol; 2020 Jul; 26(26):3834-3850. PubMed ID: 32774061
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori infection and precancerous lesions of the stomach.
Valle J; Gisbert JP
Hepatogastroenterology; 2001; 48(42):1548-51. PubMed ID: 11813569
[TBL] [Abstract][Full Text] [Related]
13. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
Wong BC; Zhang L; Ma JL; Pan KF; Li JY; Shen L; Liu WD; Feng GS; Zhang XD; Li J; Lu AP; Xia HH; Lam S; You WC
Gut; 2012 Jun; 61(6):812-8. PubMed ID: 21917649
[TBL] [Abstract][Full Text] [Related]
14. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
You WC; Brown LM; Zhang L; Li JY; Jin ML; Chang YS; Ma JL; Pan KF; Liu WD; Hu Y; Crystal-Mansour S; Pee D; Blot WJ; Fraumeni JF; Xu GW; Gail MH
J Natl Cancer Inst; 2006 Jul; 98(14):974-83. PubMed ID: 16849680
[TBL] [Abstract][Full Text] [Related]
15. Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.
Giuliani A; Spada S; Corona M; Demoro M; Di Bari M; Ricciardulli T; Galati G; Caporale A; Tocchi A; Angelico F
J Exp Clin Cancer Res; 2003 Sep; 22(3):371-8. PubMed ID: 14582693
[TBL] [Abstract][Full Text] [Related]
16. [Changes of gastric mucosa histopathology after Helicobacter pylori eradication].
Zhou LY; Shen ZY; Lin SR; Jin Z; Ding SG; Huang XB; Xia ZW; Liu JJ; Guo HL; William C
Zhonghua Nei Ke Za Zhi; 2003 Mar; 42(3):162-4. PubMed ID: 12816696
[TBL] [Abstract][Full Text] [Related]
17. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
Leung WK; Lin SR; Ching JY; To KF; Ng EK; Chan FK; Lau JY; Sung JJ
Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578
[TBL] [Abstract][Full Text] [Related]
18. Does treatment of Helicobacter pylori infection reduce gastric precancerous lesions?
Mansour-Ghanaei F; Joukar F; Mojtahedi K; Sokhanvar H; Askari K; Shafaeizadeh A
Asian Pac J Cancer Prev; 2015; 16(4):1571-4. PubMed ID: 25743833
[TBL] [Abstract][Full Text] [Related]
19. H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole.
Yang HB; Sheu BS; Wang ST; Cheng HC; Chang WL; Chen WY
Am J Gastroenterol; 2009 Jul; 104(7):1642-9. PubMed ID: 19436275
[TBL] [Abstract][Full Text] [Related]
20. Histological changes of gastric mucosa after Helicobacter pylori eradication: a systematic review and meta-analysis.
Kong YJ; Yi HG; Dai JC; Wei MX
World J Gastroenterol; 2014 May; 20(19):5903-11. PubMed ID: 24914352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]